Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma IPOs Start To Gear Up For 2013 After A Lull

Jan 21 2013

• By Stacy Lawrence

Related Content

Alder Obtains First Milestone Under BMS Deal, Advances Own Program In Cancer Supportive Care

Jun 21 2011

More And Better Biotech IPOs, But Step-Ups Still Lag

Oct 01 2012

Verastem Joins The Public Markets With A Strong IPO

Jan 27 2012

JOBS Gets To Work On IPOs, Companies Cherry Pick Benefits

Nov 14 2012

Celgene Licenses Lead Program From Epizyme, Takes Option To Remaining Pipeline

Apr 26 2012

Related Companies

Intercept Pharmaceuticals, Inc.

Kythera Biopharmaceuticals, Inc.

LipoScience Inc.

Agilent Technologies, Inc.

Humanigen, Inc.

Sanofi

Baxter International Inc.

OncoMed Pharmaceuticals, Inc.

GSK plc

Alder Biopharmaceuticals, Inc.

Bristol Myers Squibb Company

Onconova Therapeutics, Inc.

Agios Pharmaceuticals, Inc.

Epizyme, Inc.

Bristol Myers Squibb Company

Verastem, Inc.

Additional Topics

Deals Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window